Chargement en cours...
Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by T(reg) depletion
Despite the success of passive immunotherapy with monoclonal antibodies (mAbs), many lymphoma patients eventually relapse. Induction of an adaptive immune response may elicit active and long-lasting antitumor immunity, thereby preventing or delaying recurrence. Immunomodulating mAbs directed against...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2765679/ https://ncbi.nlm.nih.gov/pubmed/19641184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-05-223958 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|